Saporta D and McDaniel A. Efficacy Comparison of Multiple-Antigen Subcutaneous Injection Immunotherapy and Multiple-Antigen Sublingual Immunotherapy. ENT Journal 2007; 86(8):493-497
Saporta D. Sublingual Immunotherapy: A Novel, Albeit Not So New, Immunotherapy Treatment Modality Am J Rhinology 22,1-00,2008; doi: 10.2500/ajr.2008.22.3131
Saporta D. Sublingual Immunotherapy and Asthma. Townsend Letter 2010;327:44-48
Saporta D. Sublingual Immunotherapy: An Alternative to Allergy Shots. Townsend letter 2012; 345:64-68
Saporta D. Changes in Peak Flow Meter Values During Immunotherapy Administration. Journal of Environmental and Public Health Volume 2012, Article ID 212867, 9 pages. doi:10.1155/2012/212867
Saporta D. Efficacy of Sublingual Immunotherapy versus Subcutaneous Injection Immunotherapy in Allergic Patients. Journal of Environmental and Public Health Volume 2012, Article ID 492405, 6 pages doi:10.1155/2012/492405
Kalyoussef E. and Saporta D. Urticaria and Angioedema after Intraturbinal Injection of Steroids. Clinical and Experimental Medical Sciences, Vol. 1, 2013, no. 5, 217 – 232. dx.doi.org/10.12988/cems.2013.13018
Saporta D. Reactions to Sublingual Immunotherapy: An Analysis of a Group of Patients Who Developed Adverse Events over a Period of 5 Years. Townsend letter – August/September 2014:78-79.
On line version: Reactions to Sub-Lingual Immunotherapy: An Analysis of a Group of Patients Who Developed Adverse Events over a Period of 5 Years. Does Glycerin play a role? by Diego Saporta, MD
Saporta D. Low-Dose Allergen Immunotherapy (LDA) vs. Subcutaneous Injection Immunotherapy: A Comparative study. Townsend Letter June 2015: 62-66
Saporta D and Hurst D. Increased Sensitization to Mold Allergens Measured by Intradermal Skin Testing following Hurricanes, Journal of Environmental and Public Health 2017 (2017), Article ID 2793820. https://doi.org/10.1155/2017/2793820
Saporta D and Hurst D. Management of the allergic patient: The role of different diagnostic tests. Townsend Letter April 2018:52-55.
Saporta D and Hurst D. Management of the Allergic Patient. The role of a Changing Environment. Townsend letter May 2018:63-66.
Saporta, D. Prevalence and Role of the Delayed Reaction in the Management of the Allergic Patient. Townsend Letter April 2020:55-61
Saporta D. Immunotherapy Management of the Allergic Patient with Asthma and Lower Airway Inflammation. Townsend Letter April 2021:38-45. (References available online at townsendletter.com).
Saporta, D. The Role of the Peak Flow Meter in the Management of the Patient Receiving Allergy Immunotherapy. TOWNSEND LETTER – APRIL 2022:35-38
Letter to Editor. Allergy Management. Townsend Letter June 2022:61-62
Hurst DS, Gordon B, McDaniel AB and Diego Saporta D. Letter to the Editor Regarding Eosinophilic Otitis Media. Ear, Nose & Throat Journal 2022, Vol. 0(0) 1–2. DOI: 10.1177/01455613221104502